Print

Hyperion Therapeutics Appoints Daniel G. Welch to Board of Directors  
8/29/2012 9:35:12 AM

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2012 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that it has named Daniel G. Welch to its Board of Directors. Mr. Welch currently serves as Chairman, Chief Executive Officer and President of InterMune, Inc., a public biotechnology company based in Brisbane, California.
//-->